Stocklytics Platform
Asset logo for symbol PRFX
PainReform Ltd.
PRFX44
$0.53arrow_drop_up2.07%$0.01
Penny Stock
Asset logo for symbol PRFX
PRFX44

$0.53

arrow_drop_up2.07%

Performance History

Chart placeholder
Key Stats
Open$0.55
Prev. Close$0.52
EPS-36.84
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$1.29M
PE Ratio-
LOWHIGH
Day Range0.51
0.57
52 Week Range0.42
20.16
Ratios
Revenue-
EBITDA Margin %-
EPS-36.84

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About PainReform Ltd. (PRFX)

PainReform Ltd. (PRFX) is a pharmaceutical company specializing in the development and commercialization of novel pain management therapies. The company's mission is to improve the quality of life for patients suffering from chronic pain by providing innovative and effective treatment options. PRFX stock has shown resilience in the market, with a steady increase in price over the years.
The company's stock price history reflects its growth potential and investor confidence. Despite market fluctuations, PRFX has consistently performed well, demonstrating its stability and strong market position. Investors can rely on PainReform Ltd.'s track record of success and its commitment to delivering value to shareholders.
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
CEO
Mr. Ilan Hadar M.B.A., MBA
Headquarters
Tel Aviv
Employees
6
Exchange
NASDAQ
add PainReform Ltd. to watchlist

Keep an eye on PainReform Ltd.

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the 52-week high and low for PainReform Ltd. (PRFX)?

For PainReform Ltd. (PRFX), the 52-week high is $20.16, which is 3.7K% from the current price. The 52-week low is $0.43, the current price is 24.6% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

What is PainReform Ltd.'s (PRFX) price per share?

The current price per share for PainReform Ltd. (PRFX) is $0.53. The stock has seen a price change of $0.01 recently, indicating a 2.08% change. This reflects the stock's recent market performance and investor sentiment.
help

Is PainReform Ltd. (PRFX) a growth stock?

PainReform Ltd. (PRFX) has shown an average price growth of -6.65% over the past three years. It has received a score of -3 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying PainReform Ltd. as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is PainReform Ltd. (PRFX) stock price performance year to date (YTD)?

As of the latest data, PainReform Ltd. (PRFX) has a year-to-date price change of -96.57%. Over the past month, the stock has experienced a price change of -23.07%. Over the last three months, the change has been -73.75%. Over the past six months, the figure is -88.94%.
help

Is PainReform Ltd. (PRFX) a profitable company?

PainReform Ltd. (PRFX) has a net income of -$9.34M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$9.58M. Furthermore, the EBITDA is -$17.81M.
help

What is the market capitalization of PainReform Ltd. (PRFX)?

PainReform Ltd. (PRFX) has a market capitalization of $1.3M. The average daily trading volume is 0.52, indicating the stock's liquidity and investor engagement.

News

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level